Company news

Pulse Biosciences, Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Pulse Biosciences to Participate in the Jefferies Healthcare Conference

May 23, 2021

Pulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual Conference

May 12, 2021

Pulse Biosciences Reports First Quarter 2021 Financial Results

May 9, 2021

Pulse Biosciences Schedules First Quarter 2021 Financial Results Conference Call for May 10, 2021

April 25, 2021

Pulse Biosciences to Present Consumer Research on Patient Perceptions of Benign Lesion Clearance at American Academy of Dermatology VMX Meeting 2021

April 21, 2021

Pulse Biosciences to Participate in Upcoming Investor Conferences

March 4, 2021

Pulse Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results

February 21, 2021

Pulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled Launch

February 18, 2021

Pulse Biosciences Announces Start of Controlled Launch of the CellFX System®

February 15, 2021

Pulse Biosciences Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for February 22, 2021

February 11, 2021

Pulse Biosciences, Inc. Announces At-The-Market Equity Offering Program

February 3, 2021

Pulse Biosciences Announces FDA Clearance for the CellFX® System

February 2, 2021

Pulse Biosciences Announces CE Mark Approval for CellFX® System

January 24, 2021

Pulse Biosciences Updates on CellFX System Regulatory and Clinical Study Progress

January 11, 2021

Pulse Biosciences, Inc. Announces Redemption of Warrants

January 4, 2021

Pulse Biosciences Grants Equity Incentive Awards To New Employees

December 14, 2020

Pulse Biosciences Presents Update on Nano-Pulse Stimulation™ Technology at Prestigous Energy-Based Devices and Aesthetic Dermatology Conference

December 3, 2020

Pulse Biosciences Reports Third Quarter 2020 Financial Results

November 8, 2020

Pulse Biosciences Schedules Third Quarter 2020 Financial Results Conference Call for November 9, 2020

October 27, 2020

Pulse Biosciences Announces Presentation of Clinical Results Using Nano-Pulse Stimulation Technology for the Clearance of Skin Lesions at the American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting

October 6, 2020

Pulse Biosciences Announces FDA IDE Approval and Initiation of Sebaceous Hyperplasia Study

September 30, 2020

Pulse Biosciences Announces Receipt of MDSAP Certification

September 28, 2020

Pulse Biosciences Reports Second Quarter 2020 Financial Results

August 9, 2020

Pulse Biosciences, Inc. Appoints Richard van den Broek to Board of Directors

August 5, 2020

Pulse Biosciences Schedules Second Quarter 2020 Financial Results Conference Call for August 10, 2020

July 26, 2020

Nano-Pulse Stimulation™ Technology Produces Favorable Results in Several Clinical Studies Presented at the 2020 Laser Medicine and Surgery Virtual Annual Conference

June 30, 2020

Pulse Biosciences, Inc. Announces Closing of $30 Million Rights Offering

June 15, 2020

Pulse Biosciences, Inc. Announces Further Details of Oversubscribed Rights Offering

June 9, 2020

Pulse Biosciences, Inc. Announces Preliminary Results for Its Oversubscribed Rights Offering

June 7, 2020

Pulse Biosciences Reports First Quarter 2020 Financial Results

May 10, 2020

Pulse Biosciences, Inc. Announces Updated Structure, Dates and Pricing Terms for Rights Offering

April 30, 2020

Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020

April 28, 2020

Pulse Biosciences Grants Equity Incentive Awards to New Employees

March 16, 2020

Pulse Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results

March 15, 2020

Pulse Biosciences Schedules Fourth Quarter and Full Year 2019 Financial Results Conference Call for March 16, 2020

March 8, 2020

Pulse Biosciences to Participate in the Cowen Health Care Conference

February 18, 2020

Pulse Biosciences Provides Update on FDA 510(k) Submission for the CellFX System in Dermatology

February 12, 2020

Pulse Biosciences to Present Data on Nano-Pulse Stimulation Technology for Nodular Basal Cell Carcinoma at IMCAS World Congress 2020

January 28, 2020

Pulse Biosciences Updates on Regulatory Progress

December 17, 2019

Pulse Biosciences Quarterly Investor Conference Call

November 6, 2019

Pulse Biosciences Announces Transition of Chief Financial Officer

November 6, 2019

Pulse Biosciences to Report Third Quarter 2019 Operational Highlights and Financial Results

October 30, 2019

Pulse Biosciences Presents Data From Several Clinical Studies of Nano-Pulse Stimulation Technology™ to Clear Skin Lesions at the 2019 ASDS Annual Meeting

October 16, 2019

Pulse Biosciences Announces Scientific Presentations of Nano-Pulse Stimulation™ Technology at Key Medical Aesthetic Meetings

September 30, 2019

← Newer news releases

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 11 decks. Every deck is listed under its year.